U-34728E (HCl)

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 597951

CAS#: 58801-45-9

Description: U-34728E (HCl) is a bioactive chemical.

Chemical Structure

U-34728E (HCl)
CAS# 58801-45-9

Theoretical Analysis

MedKoo Cat#: 597951
Name: U-34728E (HCl)
CAS#: 58801-45-9
Chemical Formula: C19H37Cl3N2O6S
Exact Mass: 0.00
Molecular Weight: 527.920
Elemental Analysis: C, 43.23; H, 7.06; Cl, 20.14; N, 5.31; O, 18.18; S, 6.07

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Related CAS #: 40984-87-0 (free base)    

Synonym: U-34728E (HCl); U34728E (HCl); U 34728E (HCl);

IUPAC/Chemical Name: (2S,4R)-N-((1S,2S)-2-chloro-1-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)tetrahydro-2H-pyran-2-yl)propyl)-1-(2-hydroxyethyl)-4-propylpyrrolidine-2-carboxamide dihydrochloride


InChi Code: InChI=1S/C19H35ClN2O6S.2ClH/c1-4-5-11-8-12(22(9-11)6-7-23)18(27)21-13(10(2)20)17-15(25)14(24)16(26)19(28-17)29-3;;/h10-17,19,23-26H,4-9H2,1-3H3,(H,21,27);2*1H/t10-,11+,12-,13+,14-,15+,16+,17+,19+;;/m0../s1

SMILES Code: CCC[C@@H]1C[C@@H](C(N[C@@H]([C@H]2O[C@@H]([C@@H]([C@H]([C@H]2O)O)O)SC)[C@@H](Cl)C)=O)N(C1)CCO.Cl.Cl

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.03.00

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 527.92 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.


Dilution Calculator

Calculate the dilution required to prepare a stock solution.

1: Olszewski G, Boryło A, Skwarzec B. Uranium ((234)U, (235)U and (238)U) contamination of the environment surrounding phosphogypsum waste heap in Wiślinka (northern Poland). J Environ Radioact. 2015 Aug;146:56-66. doi: 10.1016/j.jenvrad.2015.04.001. Epub 2015 Apr 24. PubMed PMID: 25913057.

2: Basu A, Brown ST, Christensen JN, DePaolo DJ, Reimus PW, Heikoop JM, Woldegabriel G, Simmons AM, House BM, Hartmann M, Maher K. Isotopic and Geochemical Tracers for U(VI) Reduction and U Mobility at an in Situ Recovery U Mine. Environ Sci Technol. 2015 May 19;49(10):5939-47. doi: 10.1021/acs.est.5b00701. Epub 2015 May 8. PubMed PMID: 25909757.

3: Weck PF, Kim E. Assessing Hubbard-corrected AM05+U and PBEsol+U density functionals for strongly correlated oxides CeO(2) and Ce(2)O(3). Phys Chem Chem Phys. 2016 Sep 29;18(38):26816-26826. PubMed PMID: 27711607.

4: Lowson RT, McIntyre MG. (234)U/(238)U signatures associated with uranium ore bodies: part 2 Manyingee. J Environ Radioact. 2013 Apr;118:157-62. doi: 10.1016/j.jenvrad.2012.10.006. Epub 2012 Nov 20. PubMed PMID: 23182403.

5: Latta DE, Mishra B, Cook RE, Kemner KM, Boyanov MI. Stable U(IV) complexes form at high-affinity mineral surface sites. Environ Sci Technol. 2014;48(3):1683-91. doi: 10.1021/es4047389. Epub 2014 Jan 22. PubMed PMID: 24404905.

6: Yuan K, Ilton ES, Antonio MR, Li Z, Cook PJ, Becker U. Electrochemical and Spectroscopic Evidence on the One-Electron Reduction of U(VI) to U(V) on Magnetite. Environ Sci Technol. 2015 May 19;49(10):6206-13. doi: 10.1021/acs.est.5b00025. Epub 2015 Apr 30. PubMed PMID: 25893535.

7: Reutrakul S, Wroblewski K, Brown RL. Clinical use of U-500 regular insulin: review and meta-analysis. J Diabetes Sci Technol. 2012 Mar 1;6(2):412-20. Review. PubMed PMID: 22538155; PubMed Central PMCID: PMC3380787.

8: Cao F, Kang X, Wang L. [Effects of cinobufagin on apoptosis in U-2OS osteosarcomas cells]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2014 Mar;28(3):349-53. Chinese. PubMed PMID: 24844018.

9: Foroutan-Nejad C, Vícha J, Marek R, Patzschke M, Straka M. Unwilling U-U bonding in U2@C80: cage-driven metal-metal bonds in di-uranium fullerenes. Phys Chem Chem Phys. 2015 Oct 7;17(37):24182-92. doi: 10.1039/c5cp04280a. Epub 2015 Sep 1. PubMed PMID: 26325667.

10: de la Peña A, Riddle M, Morrow LA, Jiang HH, Linnebjerg H, Scott A, Win KM, Hompesch M, Mace KF, Jacobson JG, Jackson JA. Pharmacokinetics and pharmacodynamics of high-dose human regular U-500 insulin versus human regular U-100 insulin in healthy obese subjects. Diabetes Care. 2011 Dec;34(12):2496-501. doi: 10.2337/dc11-0721. Epub 2011 Oct 12. Erratum in: Diabetes Care. 2014 Aug;37(8):2414. PubMed PMID: 21994429; PubMed Central PMCID: PMC3220843.

11: Eby EL, Zagar AJ, Wang P, Curtis BH, Xie J, Haldane DC, Idris I, Peters AL, Hood RC, Jackson JA. Healthcare costs and adherence associated with human regular U-500 versus high-dose U-100 insulin in patients with diabetes. Endocr Pract. 2014 Jul;20(7):663-70. doi: 10.4158/EP13407.OR. PubMed PMID: 24449672.

12: Tsompos C, Panoulis C, Toutouzas K, Zografos G, Papalois A. The Effect of the Antioxidant Drug "U-74389G" on Creatinine Levels during Ischemia Reperfusion Injury in Rats. Curr Urol. 2016 May;9(2):73-8. doi: 10.1159/000442857. Epub 2016 May 20. PubMed PMID: 27390579; PubMed Central PMCID: PMC4911526.

13: Peyrard T, Lam Y, Saison C, Arnaud L, Babinet J, Rouger P, Bierling P, Janvier D. Anti-U-like as an alloantibody in S-s-U- and S-s-U+(var) black people. Transfusion. 2012 Mar;52(3):622-8. doi: 10.1111/j.1537-2995.2011.03318.x. Epub 2011 Aug 31. PubMed PMID: 21880045.

14: Lam OP, Franke SM, Heinemann FW, Meyer K. Reactivity of U-E-U (E = S, Se) toward CO2, CS2, and COS: new mixed-carbonate complexes of the types U-CO2E-U (E = S, Se), U-CS2E-U (E = O, Se), and U-COSSe-U. J Am Chem Soc. 2012 Oct 10;134(40):16877-81. doi: 10.1021/ja307539w. Epub 2012 Sep 28. PubMed PMID: 22970905.

15: Mathers C, Spencer CM, Munger J. Distinct domains within the human cytomegalovirus U(L)26 protein are important for wildtype viral replication and virion stability. PLoS One. 2014 Feb 5;9(2):e88101. doi: 10.1371/journal.pone.0088101. eCollection 2014. Erratum in: PLoS One. 2014;9(12):e114927. PubMed PMID: 24505393; PubMed Central PMCID: PMC3914908.

16: Yang Y, Zhang P. First-principles molecular dynamics study of water dissociation on the γ-U(1 0 0) surface. J Phys Condens Matter. 2015 May 8;27(17):175005. doi: 10.1088/0953-8984/27/17/175005. Epub 2015 Apr 2. PubMed PMID: 25835568.

17: Jemison NE, Johnson TM, Shiel AE, Lundstrom CC. Uranium Isotopic Fractionation Induced by U(VI) Adsorption onto Common Aquifer Minerals. Environ Sci Technol. 2016 Nov 15;50(22):12232-12240. Epub 2016 Oct 28. PubMed PMID: 27758097.

18: Harrison JJ, Payne TE, Wilsher KL, Thiruvoth S, Child DP, Johansen MP, Hotchkis MA. Measurement of (233)U/(234)U ratios in contaminated groundwater using alpha spectrometry. J Environ Radioact. 2016 Jan;151 Pt 3:537-41. doi: 10.1016/j.jenvrad.2015.08.013. Epub 2015 Sep 7. PubMed PMID: 26359847.

19: Lowson RT. (234)U/(238)U signatures associated with uranium ore bodies: part 3 Koongarra. J Environ Radioact. 2013 Apr;118:163-8. doi: 10.1016/j.jenvrad.2012.10.004. Epub 2012 Nov 8. PubMed PMID: 23142336.

20: Mougel V, Pécaut J, Mazzanti M. New polynuclear U(IV)-U(V) complexes from U(IV) mediated uranyl(V) disproportionation. Chem Commun (Camb). 2012 Jan 21;48(6):868-70. doi: 10.1039/c1cc16646h. Epub 2011 Dec 1. PubMed PMID: 22134746.